Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
advocacy, Bio, Biopharma, breakthrough, Burkly, cure, discretion, hematological, HSC, intermediate, Linda, middle, October, regenerative, reverse, surrogate, timeframe, Vor, written
Removed:
remain, track, workforce
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view